Statistical significance is widely used to evaluate research findings but has limitations around reproducibility. Measures of statistical fragility aim to quantify robustness against violations of assumptions. However, dependence on sample size and single unit changes restricts indices like the unit fragility index and the fragility quotient. The Robustness Index (RI) is proposed to overcome these limitations and quantify fragility independently of the research study's sample size. The RI measures how altering sample size affects significance. For insignificant findings, the sample size is multiplied until significance is reached; the multiplicand is the RI. The sample size is divided for significant research findings until insignificance i...
Abstract Background Clinical trials routinely have pa...
Objectives: The Fragility Index, which represents the number of patients responsible for a statistic...
The Gross-Error Sensitivity (GES) and the Breakdown Point (BP) are two measures of quantitative robu...
This article proposes the Percent Fragility Index (PFI) as an improved measure of statistical fragil...
Objective:The fragility index is a clinically interpretable metric increasingly used to interpret th...
Rationale Aims and Objectives: The fragility index (FI) and fragility quotient (FQ) are increasingly...
AbstractObjectivesA P-value <0.05 is one metric used to evaluate the results of a randomized control...
Data suggest inadequacy of common statistical techniques for reporting outcomes in clinical trials. ...
The uncertainty that researchers face in specifying their estimation model threatens the validity of...
OBJECTIVES:To perform fragility index (FI) analysis on the evidence that forms the basis of the guid...
Background: RCTs (randomized controlled trials) are the preferred source of evidence to support prof...
More than one million peri-operative patients die each year. Thus, small improvements in peri-opera...
<p>Note:</p><p>** and *** indicate significance level at the 5% and 1% levels respectively.</p><p>Ro...
Background: RCTs (randomized controlled trials) are the preferred source of evidence to support prof...
Aims: Guidelines for the management of chronic heart failure (CHF) cite the results of randomized co...
Abstract Background Clinical trials routinely have pa...
Objectives: The Fragility Index, which represents the number of patients responsible for a statistic...
The Gross-Error Sensitivity (GES) and the Breakdown Point (BP) are two measures of quantitative robu...
This article proposes the Percent Fragility Index (PFI) as an improved measure of statistical fragil...
Objective:The fragility index is a clinically interpretable metric increasingly used to interpret th...
Rationale Aims and Objectives: The fragility index (FI) and fragility quotient (FQ) are increasingly...
AbstractObjectivesA P-value <0.05 is one metric used to evaluate the results of a randomized control...
Data suggest inadequacy of common statistical techniques for reporting outcomes in clinical trials. ...
The uncertainty that researchers face in specifying their estimation model threatens the validity of...
OBJECTIVES:To perform fragility index (FI) analysis on the evidence that forms the basis of the guid...
Background: RCTs (randomized controlled trials) are the preferred source of evidence to support prof...
More than one million peri-operative patients die each year. Thus, small improvements in peri-opera...
<p>Note:</p><p>** and *** indicate significance level at the 5% and 1% levels respectively.</p><p>Ro...
Background: RCTs (randomized controlled trials) are the preferred source of evidence to support prof...
Aims: Guidelines for the management of chronic heart failure (CHF) cite the results of randomized co...
Abstract Background Clinical trials routinely have pa...
Objectives: The Fragility Index, which represents the number of patients responsible for a statistic...
The Gross-Error Sensitivity (GES) and the Breakdown Point (BP) are two measures of quantitative robu...